Compare LEGN & CHYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LEGN | CHYM |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 7.0B |
| IPO Year | 2020 | N/A |
| Metric | LEGN | CHYM |
|---|---|---|
| Price | $18.59 | $22.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 16 |
| Target Price | ★ $63.46 | $33.07 |
| AVG Volume (30 Days) | 2.2M | ★ 3.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $67.72 | $21.87 |
| Revenue Next Year | $43.82 | $18.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.24 | $16.17 |
| 52 Week High | $45.30 | $38.67 |
| Indicator | LEGN | CHYM |
|---|---|---|
| Relative Strength Index (RSI) | 45.49 | 51.17 |
| Support Level | $16.24 | $16.95 |
| Resistance Level | $23.68 | $27.43 |
| Average True Range (ATR) | 0.91 | 1.44 |
| MACD | 0.29 | 0.39 |
| Stochastic Oscillator | 29.91 | 66.18 |
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Chime Financial Inc is a financial technology company that believes in core banking services.